These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14562000)

  • 1. Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL.
    Ivanov V; Faucher C; Bilger K; Vey N; Sainty D; Calmels B; Chabannon C; Lafage-Pochitaloff M; Mozziconacci MJ; Mohty M; Chrestian MA; Blaise D
    Bone Marrow Transplant; 2003 Nov; 32(9):961-3. PubMed ID: 14562000
    [No Abstract]   [Full Text] [Related]  

  • 2. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
    Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.
    Montero A; Savani BN; Shenoy A; Read EJ; Carter CS; Leitman SF; Mielke S; Rezvani K; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1318-25. PubMed ID: 17162214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute skin GVHD following syngeneic BMT for CLL.
    Deane M; Singer C; Lawler M; McElwaine S; Gomez K; Prentice HG
    Bone Marrow Transplant; 1998 Dec; 22(12):1207-9. PubMed ID: 9894725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease.
    Neumann S; Schoppmeyer K; Lange T; Wiedmann M; Golsong J; Tannapfel A; Mossner J; Niederwieser D; Caca K
    Gastrointest Endosc; 2007 Mar; 65(3):403-9. PubMed ID: 17321239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
    Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
    Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
    Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of donor-derived CLL 8 years after sibling donor SCT for CML.
    Perz JB; Ritgen M; Moos M; Ho AD; Kneba M; Dreger P
    Bone Marrow Transplant; 2008 Nov; 42(10):687-8. PubMed ID: 18679371
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft-versus-leukemia in chronic lymphocytic leukemia.
    Ben-Bassat I; Raanani P; Gale RP
    Bone Marrow Transplant; 2007 Apr; 39(8):441-6. PubMed ID: 17322931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
    Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
    J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy.
    Vural F; Donmez A; Doganavşargil B; Cagýrgan S; Alper H; Tombuloglu M
    Transfus Apher Sci; 2005 Oct; 33(2):129-33. PubMed ID: 16150645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases.
    Sohn SK; Kim DH; Kim JG; Sung WJ; Baek JH; Lee NY; Won DI; Suh JS; Lee KS; Lee KB
    Eur J Haematol; 2004 Jun; 72(6):430-6. PubMed ID: 15128422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: novel molecular diagnostic tools for a challenging differential diagnosis.
    Romagnani P; Lazzeri E; Mazzinghi B; Lasagni L; Guidi S; Bosi A; Cirami C; Salvadori M
    Am J Kidney Dis; 2005 Sep; 46(3):550-6. PubMed ID: 16129218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute graft-versus-host disease (GVHD) overlapping chronic GVHD after reinduction chemotherapy.
    Delgado-Jimenez Y; Goiriz R; Vargas-Diez E; Fraga J; Garcia-Diez A; Fernandez-Herrera J
    Br J Dermatol; 2007 Feb; 156(2):388-90. PubMed ID: 17223891
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.